MicroRNA-21 is involved in osteosarcoma cell invasion and migration

Wu Ziyan1, Yang Shuhua, Weng Xiufang

  • 1Department of Orthopedics, Union Hospital, and Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road 1277, 430022, Wuhan, China.

Insights

MicroRNA-21 (miR-21) is overexpressed in osteosarcoma, driving cancer cell invasion and migration. Targeting miR-21 may offer a new therapeutic strategy by affecting the tumor suppressor gene RECK.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs regulate gene expression and are implicated in various cancers.
  • MicroRNA-21 (miR-21) is an oncomiR overexpressed in many tumor types.
  • The specific role of miR-21 in osteosarcoma remains largely undefined.

Purpose of the Study:

  • To investigate the role and mechanism of miR-21 in osteosarcoma.
  • To determine if miR-21 influences cell invasion and migration in osteosarcoma.
  • To identify potential targets of miR-21 in osteosarcoma.

Main Methods:

  • Quantitative analysis of miR-21 expression in osteosarcoma tissues.
  • In vitro experiments involving miR-21 knockdown in MG-63 cells.
  • Luciferase reporter assays to confirm direct targeting of RECK by miR-21.
  • Western blot analysis to assess RECK protein levels.

Main Results:

  • miR-21 was significantly overexpressed in osteosarcoma tissues compared to controls.
  • Knockdown of miR-21 markedly reduced cell invasion and migration in MG-63 osteosarcoma cells.
  • RECK (reversion-inducing-cysteine-rich protein with kazal motifs), a known tumor suppressor, was identified as a direct target of miR-21.
  • RECK protein expression was inversely correlated with miR-21 expression in osteosarcoma tissues.

Conclusions:

  • miR-21 plays a crucial role in regulating cellular invasion and migration in osteosarcoma.
  • miR-21 likely exerts its oncogenic function by downregulating the tumor suppressor RECK.
  • miR-21 represents a potential therapeutic target for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...